WallStreetZenWallStreetZen

NYSE: DNA
Ginkgo Bioworks Holdings Inc Stock

Open Broker Account
$2.89+0.09 (+3.21%)
Updated Sep 27, 2022
DNA Price
$2.89
Fair Value Price
N/A
Market Cap
$5.16B
52 Week Low
$2.09
52 Week High
$15.86
P/E
-1.42x
P/B
3.36x
P/S
6.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$639.50M
Earnings
-$2.96B
Gross Margin
62.7%
Operating Margin
-463.34%
Profit Margin
-463.2%
Debt to Equity
0.28
Operating Cash Flow
-$290M
Beta
2.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

DNA Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DNA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DNA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DNA is good value based on its book value relative to its share price (3.36x), compared to the US Biotechnology industry average (4.3x)
P/B vs Industry Valuation
DNA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DNA due diligence checks available for Premium users.

Be the first to know about important DNA news, forecast changes, insider trades & much more!

DNA News

Valuation

DNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.42x
Industry
15.18x
Market
28.09x

DNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.36x
Industry
4.3x
DNA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DNA's financial health

Profit margin

Revenue
$245.0M
Net Income
-$668.8M
Profit Margin
-273%
DNA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DNA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.0B
Liabilities
$427.2M
Debt to equity
0.28
DNA's short-term assets ($1.60B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DNA's short-term assets ($1.60B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DNA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$99.3M
Investing
-$14.7M
Financing
-$954.0k
DNA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

DNA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
DNA$5.16B+3.21%-1.42x3.36x
EXEL$5.12B+0.06%18.71x2.14x
HALO$5.32B+0.16%14.86x18.16x
CRSP$4.96B+4.14%-7.69x2.37x
ASND$5.59B+1.51%-14.00x9.01x

Ginkgo Bioworks Holdings Stock FAQ

What is Ginkgo Bioworks Holdings's quote symbol?

NYSE: DNA) Ginkgo Bioworks Holdings trades on the NYSE under the ticker symbol DNA. Ginkgo Bioworks Holdings stock quotes can also be displayed as NYSE: DNA.

If you're new to stock investing, here's how to buy Ginkgo Bioworks Holdings stock.

What is the 52 week high and low for Ginkgo Bioworks Holdings (NYSE: DNA)?

(NYSE: DNA) Ginkgo Bioworks Holdings's 52-week high was $15.86, and its 52-week low was $2.09. It is currently -81.78% from its 52-week high and 38.28% from its 52-week low.

How much is Ginkgo Bioworks Holdings stock worth today?

(NYSE: DNA) Ginkgo Bioworks Holdings currently has 1,784,832,817 outstanding shares. With Ginkgo Bioworks Holdings stock trading at $2.89 per share, the total value of Ginkgo Bioworks Holdings stock (market capitalization) is $5.16B.

Ginkgo Bioworks Holdings stock was originally listed at a price of $10.88 in Feb 24, 2021. If you had invested in Ginkgo Bioworks Holdings stock at $10.88, your return over the last 1 years would have been -73.44%, for an annualized return of -73.44% (not including any dividends or dividend reinvestments).

How much is Ginkgo Bioworks Holdings's stock price per share?

(NYSE: DNA) Ginkgo Bioworks Holdings stock price per share is $2.89 today (as of Sep 27, 2022).

What is Ginkgo Bioworks Holdings's Market Cap?

(NYSE: DNA) Ginkgo Bioworks Holdings's market cap is $5.16B, as of Sep 28, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ginkgo Bioworks Holdings's market cap is calculated by multiplying DNA's current stock price of $2.89 by DNA's total outstanding shares of 1,784,832,817.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.